S
Susana Liu
Researcher at Merck & Co.
Publications - 19
Citations - 908
Susana Liu is an academic researcher from Merck & Co.. The author has contributed to research in topics: Renin–angiotensin system & Renin inhibitor. The author has an hindex of 12, co-authored 17 publications receiving 873 citations.
Papers
More filters
Journal ArticleDOI
Deletion of phosphodiesterase 4D in mice shortens α2-adrenoceptor–mediated anesthesia, a behavioral correlate of emesis
Annette Robichaud,Panagiota B. Stamatiou,S.-L. Catherine Jin,Nicholas Lachance,Dwight Macdonald,Susana Liu,Zheng Huang,Marco Conti,Chi-Chung Chan +8 more
TL;DR: Findings strongly support the hypothesis that inhibition of PDE4D is pivotal to the anesthesia-reversing effect of PMNPQ and is likely responsible for emesis induced by PDE 4 inhibitors.
Journal ArticleDOI
Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets.
Denis Riendeau,Jocelyne Guay,Philip K. Weech,F. Laliberte,J. Yergey,Chun-Sing Li,Sylvie Desmarais,Helene Perrier,Susana Liu,Deborah A. Nicoll-Griffith +9 more
TL;DR: The results suggest that the cPLA2 plays an important role in the generation of free AA for 12-HETE biosynthesis in platelets and affects the cyclooxygenase pathway in addition to AA release.
Journal ArticleDOI
Preferential Inhibition of T Helper 1, but Not T Helper 2, Cytokines in Vitro by L-826,141 [4-{2-(3,4-Bisdifluromethoxyphenyl)-2-{4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl}-3-methylpyridine-1-oxide], a Potent and Selective Phosphodiesterase 4 Inhibitor
David Claveau,Shiow Chen,Stephen J. O'Keefe,Dennis M. Zaller,Angela Styhler,Susana Liu,Zheng Huang,Donald W. Nicholson,Joseph A. Mancini +8 more
TL;DR: It is shown that specific inhibition of PDE4 preferentially blocks the production of Th1 versus Th2 effector cytokines in vitro and rolipram and L-826,141 are potent inhibitors of CD3-plus CD28-stimulated IL-2 production in naive human T cells.
Journal ArticleDOI
Dynamic Activation of Cystic Fibrosis Transmembrane Conductance Regulator by Type 3 and Type 4D Phosphodiesterase Inhibitors
Susana Liu,Alain Veilleux,Lei Zhang,Andrew A. Young,Evonne Kwok,Christine C. Chung,Michael R. Tota,Daniel Dube,Richard Friesen,Zheng Huang +9 more
TL;DR: The activation of CFTR-mediated chloride secretion by phosphodiesterase (PDE) 4 inhibitors in T84 monolayer using 125I anion as tracer suggests that PDE3 and PDE4 form the major cAMP diffusion barrier in T 84 cells to ensure a compartmentalized CFTR signaling.
Journal ArticleDOI
Preferential inhibition of human phosphodiesterase 4 by ibudilast
Zheng Huang,Susana Liu,Lei Zhang,Myriam Salem,Gillian Greig,Chi-Chung Chan,Yutaka Natsumeda,Kazuhito Noguchi +7 more
TL;DR: The attenuated inflammatory and allergic responses from the potent and preferential PDE4 inhibition of ibudilast may have contributed significantly to its beneficial pharmacological responses and distinguishes ibudILast from the other ophthalmic solutions in the treatment of ocular allergy.